Commercial interests, transparency, and independence
Ray Moynihan, Helen Macdonald, Carl Heneghan, Lisa Bero & Fiona Godlee
Declaring interests and restoring trust in medicine
Carl Heneghan & Margaret McCartney
Industry influence in indoor tanning research
Jerod Stapleton & Joel Hillhouse
Financial relations between leaders of US medical societies and industry
Jake Checketts & Matt Vassar
Commercial influence and covid-19
Ray Moynihan, Helen Macdonald, Lisa Bero & Fiona Godlee
Pathways to Independence: towards producing and using trustworthy evidence
Ray Moynihan, Per Vandvik, Beate Wieseler, et al.
Improving researchers’ conflict of interest declarations
Quinn Grundy, Adam G Dunn & Lisa Bero
Achieving greater independence from commercial influence in research
Joel Lexchin, Lisa Bero, Courtney Davis, & Marc-Andre Gagnon
Influence and management of conflicts of interest in randomised clinical trials
Lasse Østengaard, Andreas Lundh, Tine Tjørnhøj-Thomsen et al
“Asset exchange”—interactions between patient groups and pharmaceutical industry
Lisa Parker, Alice Fabbri, Quinn Grundy, Barbara Mintzes & Lisa Bero
Effect of revealing authors’ conflicts of interests in peer review: randomized controlled trial
Leslie John, George Loewenstein, Andrew Marder & Michael Callaham
Association between gifts from pharmaceutical companies to French general practitioners and their drug prescribing patterns in 2016: retrospective study using the French Transparency in Healthcare and National Health Data System databases
Bruno Goupil, Frédéric Balusson, Florian Naudet, et al.
Association between financial links to indoor tanning industry and conclusions of published studies on indoor tanning: systematic review
Lola Adekunle, Rebecca Chen, Lily Morrison, et al.
Mixed methods evaluation of workshops for citizen health advocates about financial conflicts of interests in healthcare
Ray Moynihan, Alice Fabbri, Lisa Parker & Lisa Bero
Financial ties between leaders of influential US professional medical associations and industry: cross sectional study
Ray Moynihan, Loai Albarqouni, Conrad Nangla, Adam Dunn, Joel Lexchin, & Lisa Bero
Mechanisms for addressing and managing the influence of corporations on public health policy, research and practice: a scoping review
Melissa Mialon, Stefanie Vandevijvere, Angela Carriedo-Lutzenkirchen, et al.
Voluntary disclosures of payments from pharmaceutical companies to healthcare professionals in Germany: a descriptive study of disclosures in 2015 and 2016
Marlene Stoll, Lara Hubenschmid, Cora Koch & Klaus Lieb
Cochrane announces a new, more rigorous “conflict of interest” policy
The sun is shining on the South: advocacy and regulation of conflicts of interest in Chile
Bernardo Aguilera, Juan Carlos Almonte & Rodrigo Irarrázaval
Can expert bias be reduced in medical guidelines?